NCT03204513

Brief Summary

The overall goal of this research is to determine the efficacy of new powered prosthetic devices for individuals with transfemoral amputations. The anticipation is that this will be a high-impact technological intervention with the potential to restore significant functionality to individuals with lower limb amputation and transform the field of lower limb prosthetics. The objective of the proposed clinical trial is to fully evaluate the biomechanical and energetic effects of using PKA prosthesis and quantify functional performance and quality of life changes.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
7mo left

Started Dec 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress94%
Dec 2016Dec 2026

Study Start

First participant enrolled

December 1, 2016

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

June 22, 2017

Completed
10 days until next milestone

First Posted

Study publicly available on registry

July 2, 2017

Completed
9.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

April 22, 2026

Status Verified

April 1, 2026

Enrollment Period

10 years

First QC Date

June 22, 2017

Last Update Submit

April 21, 2026

Conditions

Keywords

ProsthesisPowered Prosthesis

Outcome Measures

Primary Outcomes (2)

  • Change between devices of the Modified Graded Treadmill Test

    This test is used to determine participant's endurance while walking at different speeds on a motorized treadmill. Participants will be secured to an overhead safety harness during this test. Participants will walk for up to 2 minutes each at different speeds on the treadmill. The treadmill speeds will be varied between 0.2 meters/second up to 2.0 meters/second at increments of 0.2 meters/sec. Close to the end of every 2 minute walk period, the participant will be asked to rate the perceived exertion for the walking task. Before incrementing the speed and continuing with the test, participants will be asked if participants would like to continue to walk and if the speed can be incremented. Participants metabolic and heart rate will be monitored frequently and recorded during this test. A physical exertion rating scale will be used to record participant's perceived exertion during every 2 minutes throughout the trial.

    Week 6-7 (Post-Training Assessments); Weeks 21-22 (Post-Training Assessment)

  • Change in Biomechanical Assessment [Gait Parameters and Surface Electromyography (EMG) Activation] Between Devices

    Surface EMG recording of specific muscles will be recorded during walking. The EMG electrodes detect electrical signals of the muscles. Reflective markers will be placed at specific locations on the upper and lower extremity joint/bony landmarks to record the motion while walking. The locations of the markers in space will be recorded by an infrared based multi-camera system during walking indoors on tile and over force plates.

    Week 6-7 (Post-Training Assessments); Weeks 21-22 (Post-Training Assessment)

Secondary Outcomes (14)

  • Change in Manual Muscle Test (MMT)

    Week 1 (Pre-Assessment); Week 6-7 (Post-Training Assessments); Weeks 21-22 (Post-Training Assessment)

  • Change in Passive Range of Motion (PROM)

    Week 1 (Pre-Assessment); Week 6-7 (Post-Training Assessments); Weeks 21-22 (Post-Training Assessment)

  • Change in Active Range of Motion (AROM)

    Week 1 (Pre-Assessment); Week 6-7 (Post-Training Assessments); Weeks 21-22 (Post-Training Assessment)

  • 6 Minute Walk Test (6MWT) with COSMED K4B2 Metabolic unit

    Week 6-7 (Post-Training Assessments); Weeks 21-22 (Post-Training Assessment)

  • Hill Assessment Index (HAI)

    Week 6-7 (Post-Training Assessments); Weeks 21-22 (Post-Training Assessment)

  • +9 more secondary outcomes

Other Outcomes (10)

  • Modified Falls Efficacy Scale (mFES)

    Week 6-7 (Post-Training Assessments); Weeks 21-22 (Post-Training Assessment)

  • Prosthesis Evaluation Questionnaire (PEQ)

    Week 6-7 (Post-Training Assessments); Weeks 21-22 (Post-Training Assessment)

  • Orthotics & Prosthetics User Survey (OPUS)

    Week 6-7 (Post-Training Assessments); Weeks 21-22 (Post-Training Assessment)

  • +7 more other outcomes

Study Arms (2)

Vanderbilt Powered Knee-Ankle Prosthesis

EXPERIMENTAL

Upon screening and enrollment participants return for up to 8 prosthetic fitting sessions and up to 12 physical therapy training sessions using the Vanderbilt Powered Knee-Ankle (PKA) Prosthesis. Once training is complete participants will return for up to 6 post-training assessment sessions using the Vanderbilt Powered Knee-Ankle (PKA) Prosthesis. The device participants begin with will be randomly selected but there will be an equal opportunity to train with both devices. In between training, there will be an 8 week "wash out period" to allow normalization to use of the device, reducing carryover effects. After wash-out period protocol will be repeated with second device.

Device: Vanderbilt Powered Knee-Ankle Prosthesis

Microprocessor (MP) Knee Prosthesis

ACTIVE COMPARATOR

Upon screening and enrollment participants return for up to 8 prosthetic fitting sessions and up to 12 physical therapy training sessions using their own Microprocessor (MP) Knee Prosthesis. Once training is complete participants will return for up to 6 post-training assessment sessions using the Microprocessor (MP) Knee Prosthesis. The device participants begin with will be randomly selected but there will be an equal opportunity to train with both devices. In between training, there will be an 8 week "wash out period" to allow normalization to use of the device, reducing carryover effects. After wash-out period protocol will be repeated with second device.

Device: Microprocessor (MP) Knee Prosthesis

Interventions

The Vanderbilt powered prosthesis is a transfemoral prosthesis with powered and coordinated knee and ankle joints. The Generation 3 prosthesis is actuated by two brushless direct current (DC) motors, providing up to 100 Nm of torque at the knee joint, and with the assistance of a parallel stiffness, up to 200 Nm in plantar flexion at the ankle. Sensors measure knee and ankle joint angles, axial load in the shank, and position and orientation of the prosthesis in space (via a 6-axis inertial measurement unit). An onboard lithium-ion battery provides sufficient energy for approximately 10,000 steps between battery charges. The prosthesis prototype weighs approximately 4.3 kg (9.5 lb), the mass of which is approximately equivalent to the intact limb of a 48 kg (105 lb) person.

Also known as: PKA Prosthesis, Powered Knee-Ankle Prosthesis
Vanderbilt Powered Knee-Ankle Prosthesis

Participants enrolled will already have their own microprocessor controlled (MP) non-powered knee prostheses as per inclusion criteria. Examples: OttoBock's C-Leg, Ossur's Rheo, Freedom Plie, Endolite Orion,etc.

Microprocessor (MP) Knee Prosthesis

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Unilateral transfemoral level limb loss or limb difference
  • K2/K3/K4 level ambulators
  • Required to use a microprocessor knee on their prosthesis

You may not qualify if:

  • Over 250 lbs body weight
  • Inactive, physically unfit
  • Cognitive deficits or visual impairment that would impair their ability to give informed consent or to follow simple instructions during the experiments
  • Pregnant women
  • Co-morbidity that interferes with the study (e.g. stroke, pace maker placement, severe ischemia cardiac disease, etc.)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shirley Ryan AbilityLab

Chicago, Illinois, 60611, United States

Location

MeSH Terms

Interventions

Knee Prosthesis

Intervention Hierarchy (Ancestors)

Joint ProsthesisProstheses and ImplantsEquipment and Supplies

Study Officials

  • Arun Jayaraman, PT, PhD

    Shirley Ryan AbilityLab

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DEVICE FEASIBILITY
Intervention Model
CROSSOVER
Model Details: Upon screening and enrollment participants return for up to 8 prosthetic fitting sessions and up to 12 physical therapy training sessions using their own microprocessor (MP) knee prosthesis and the powered knee-ankle (PKA) prosthesis. Once training is complete participants will return for up to 6 post-training assessment sessions per device. The device participants begin with will be randomly selected but there will be equal opportunity to train with both devices. In between training, there will be an 8 week "wash out period" to allow normalization to use of the device, reducing carryover effects. After wash-out period protocol will be repeated with second device.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 22, 2017

First Posted

July 2, 2017

Study Start

December 1, 2016

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

April 22, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations